NEUPHORIA THERAPEUTICS INC - PAUSES R&D EXPENDITURES FOR BNC210 IN PTSD & IS EVALUATING ALL POSSIBILITIES AS PART OF THE CO'S STRATEGIC REVIEW

Reuters · 1d ago

Please log in to view news